Article
Dundee, Scotland - A routine cell culture of a patient with epidermolysis bullosa simplex (EBS) has led to the inadvertent discovery of a revertant mutation that deactivates the original pathogenic mutation, according to Irwin McLean, Ph.D.
Dermatology Times October 2024 Recap
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Conference Recap: Fall Clinical 2024
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New TRoSA Scale Standardizes Telangiectasia Severity in Rosacea
Teledermatology is Useful and Effective for Treating CSU Patients